Digital Patient recruitment and pre-screening methodsfor atopic dermatitis

whitePaper | January 2, 2023

As a consequence of widespread consolidation of buying power within integrated healthcare networks (IHNs), Pharma, Medical Device, and Biotech sales and marketing teams are facing information gaps that threaten their sales growth if left unaddressed.

whitePaper | September 28, 2022

Specialty drugs span a wide range of disease states, from the more prevalent, yet complex, such as multiple sclerosis, to rare and orphan diseases, such as hereditary angioedema (HAE).

whitePaper | January 21, 2023

As a consequence of widespread consolidation of buying power within integrated healthcare networks (IHNs), Pharma, Medical Device, and Biotech sales and marketing teams are facing information gaps that threaten their sales growth if left unaddressed.

whitePaper | December 9, 2022

In the wake of the COVID-19 pandemic, an estimated 48 million people1 in the U.S. (under the age of 65) lost their jobs.

whitePaper | January 17, 2020

Value-based reimbursement (VBR) models are becoming more common. Success under these models depends on showing positive improvement in key metrics, but providers often struggle to accurately report the quality of care provided. A next-generation revenue cycle that combines clinically aware artificial intelligence (AI) with an unmatched foundation of evidence-based medical research and knowledge provides the transparency necessary to both accurately report care quality and directly influence the patient satisfaction quality metric. This paper reviews how a well-tuned revenue cycle can help hospitals succeed with value-based contracts, earning appropriate incentives and avoiding penalties.

whitePaper | March 31, 2022

This is the fifth annual edition of FH® Healthcare Indicators and FH® Medical Price Index, two measures developed by FAIR Health to provide clarity in a rapidly changing healthcare environment